ORIC Pharmaceuticals, Inc. (ORIC) Cash Flow Statement
ORIC Pharmaceuticals, Inc. (ORIC) generated -$111.6M of operating cash flow over the twelve months to 2026-06-30, spent $620000 on capital expenditure and had free cash flow of -$112.3M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ORICORIC Pharmaceuticals, Inc.Follow ORIC — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -45.3 | -59.5 | -75.1 | -85.7 | -112.7 | -111.0 | -111.6 | |
| Capital expenditure | 0.7 | 0.9 | 2.1 | 0.8 | 1.2 | 0.7 | -0.6 | |
| Free cash flow | -45.9 | -60.5 | -77.2 | -86.5 | -113.9 | -111.7 | -112.3 | |
| Stock-based compensation | 5.3 | 12.9 | 14.5 | 15.2 | 20.2 | 25.0 | — |
USD millions · SEC XBRL
ORIC Pharmaceuticals, Inc. — questions
- What is ORIC Pharmaceuticals, Inc.'s operating cash flow?
- -$111.6M over the twelve months to 2026-06-30.
- How much does ORIC Pharmaceuticals, Inc. spend on capital expenditure?
- $620000 over the twelve months to 2026-06-30.
- What is ORIC Pharmaceuticals, Inc.'s free cash flow?
- -$112.3M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from ORIC Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.